The 16th edition of the International Congress on Targeted Anticancer Therapies (TAT) will take place in Paris, 5-7 March 2018.
TAT 2018 focuses on early-phase development and translational research.
The programme, established by a prestigious Scientific Committee led jointly by G. Giaccone and J. Tabernero, will include Plenary sessions, Proffered Paper sessions and poster presentations by a number of international experts. Numerous targets will be presented and discussed including Immuno-, Epigenetic-, Metabolic-, Cell-cycle-, DNA-, PI3 Kinase-targets and others, as single agents or in combination.
The TAT congress and its programme is dedicated to a broad range of professionals including basic scientists, physicians and translational researchers from academic settings, industry and regulatory agencies interested in pre-clinical and early clinical development of targeted pathways. All stake-holders involved in cancer will find an opportunity at TAT 2018 for learning, discussing and networking in a very active scientific field where recent progress in knowledge has already translated into improvements in cancer patient outcome.
The TAT 2018 programme has been accredited with 19 Cat.1 ESMO MORA points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification also guarantees that a certified medical oncologist has continued to update her/his knowledge and continue to possess the necessary skills and standards for the practice of medical oncology. See here for further details.
The TAT 2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 18 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
The EACCME® awards ECMEC®s on the basis of 1 ECMEC® for one hour of CME with a maximum of 8 ECMEC®s per day.